Taken together, this study proposes a chemically regulated system of erythropoiesis that can be used as part of a peroral therapeutic strategy to treat Epo-deficiency anemia, and this study provides us with the molecular mechanisms explaining the activation of the Epo-EpoR system through the conformational change of the EpoR homodimer. Here, EPO is linked to deficiency anemia.